190 related articles for article (PubMed ID: 22952927)
1. Effective non-viral delivery of siRNA to acute myeloid leukemia cells with lipid-substituted polyethylenimines.
Landry B; Aliabadi HM; Samuel A; Gül-Uludağ H; Jiang X; Kutsch O; Uludağ H
PLoS One; 2012; 7(8):e44197. PubMed ID: 22952927
[TBL] [Abstract][Full Text] [Related]
2. Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia.
Landry B; Gül-Uludağ H; Plianwong S; Kucharski C; Zak Z; Parmar MB; Kutsch O; Jiang H; Brandwein J; Uludağ H
J Control Release; 2016 Feb; 224():8-21. PubMed ID: 26742943
[TBL] [Abstract][Full Text] [Related]
3. Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.
Plianwong S; Thapa B; Kc RB; Kucharski C; Rojanarata T; Uludağ H
Pharm Res; 2020 Feb; 37(3):46. PubMed ID: 32016611
[TBL] [Abstract][Full Text] [Related]
4. Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation.
Valencia-Serna J; Gul-Uludağ H; Mahdipoor P; Jiang X; Uludağ H
J Control Release; 2013 Dec; 172(2):495-503. PubMed ID: 23726887
[TBL] [Abstract][Full Text] [Related]
5. siRNA therapy in cutaneous T-cell lymphoma cells using polymeric carriers.
Sahin B; Fife J; Parmar MB; Valencia-Serna J; Gul-Uludağ H; Jiang X; Weinfeld M; Lavasanifar A; Uludağ H
Biomaterials; 2014 Nov; 35(34):9382-94. PubMed ID: 25128374
[TBL] [Abstract][Full Text] [Related]
6. Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers.
Aliabadi HM; Landry B; Bahadur RK; Neamnark A; Suwantong O; Uludağ H
Macromol Biosci; 2011 May; 11(5):662-72. PubMed ID: 21322108
[TBL] [Abstract][Full Text] [Related]
7. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922
[TBL] [Abstract][Full Text] [Related]
8. siRNA-mediated BCR-ABL silencing in primary chronic myeloid leukemia cells using lipopolymers.
Valencia-Serna J; Kucharski C; Chen M; Kc R; Jiang X; Brandwein J; Uludağ H
J Control Release; 2019 Sep; 310():141-154. PubMed ID: 31430499
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
Mohseni M; Kucharski C; K C RB; Nasrullah M; Jiang X; Uludağ H; Brandwein J
PLoS One; 2021; 16(6):e0251719. PubMed ID: 34157051
[TBL] [Abstract][Full Text] [Related]
10. Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers.
Aliabadi HM; Landry B; Mahdipoor P; Hsu CY; Uludağ H
Eur J Pharm Biopharm; 2012 May; 81(1):33-42. PubMed ID: 22311298
[TBL] [Abstract][Full Text] [Related]
11. A non-viral nano-delivery system targeting epigenetic methyltransferase EZH2 for precise acute myeloid leukemia therapy.
Kaundal B; Kushwaha AC; Srivastava AK; Karmakar S; Choudhury SR
J Mater Chem B; 2020 Sep; 8(37):8658-8670. PubMed ID: 32844866
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components.
Navarro G; Essex S; Sawant RR; Biswas S; Nagesha D; Sridhar S; de ILarduya CT; Torchilin VP
Nanomedicine; 2014 Feb; 10(2):411-9. PubMed ID: 23928214
[TBL] [Abstract][Full Text] [Related]
13. Selective blocking of primary amines in branched polyethylenimine with biocompatible ligand alleviates cytotoxicity and augments gene delivery efficacy in mammalian cells.
Tripathi SK; Gupta N; Mahato M; Gupta KC; Kumar P
Colloids Surf B Biointerfaces; 2014 Mar; 115():79-85. PubMed ID: 24333556
[TBL] [Abstract][Full Text] [Related]
14. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
15. Alkane-modified short polyethyleneimine for siRNA delivery.
Schroeder A; Dahlman JE; Sahay G; Love KT; Jiang S; Eltoukhy AA; Levins CG; Wang Y; Anderson DG
J Control Release; 2012 Jun; 160(2):172-6. PubMed ID: 22155553
[TBL] [Abstract][Full Text] [Related]
16. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
Wang J; Dou B; Bao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
[TBL] [Abstract][Full Text] [Related]
17. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
[TBL] [Abstract][Full Text] [Related]
18. Lipid substitution on low molecular weight (0.6-2.0 kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expression.
Bahadur KC; Landry B; Aliabadi HM; Lavasanifar A; Uludağ H
Acta Biomater; 2011 May; 7(5):2209-17. PubMed ID: 21256988
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA.
Qi L; Wu L; Zheng S; Wang Y; Fu H; Cui D
Biomacromolecules; 2012 Sep; 13(9):2723-30. PubMed ID: 22913876
[TBL] [Abstract][Full Text] [Related]
20. Silencing of myeloid cell leukemia-1 by small interfering RNA improves chemosensitivity to etoposide in u-937 leukemic cells.
Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Karimi P; Othman F
J Biol Regul Homeost Agents; 2016; 30(1):55-65. PubMed ID: 27049076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
